Literature DB >> 14522843

Tetrahydrocannabinol-induced neurotoxicity depends on CB1 receptor-mediated c-Jun N-terminal kinase activation in cultured cortical neurons.

Eric J Downer1, Marie P Fogarty, Veronica A Campbell.   

Abstract

Delta9-Tetrahydrocannabinol (THC), the main psychoactive ingredient of marijuana, induces apoptosis in cultured cortical neurons. THC exerts its apoptotic effects in cortical neurons by binding to the CB1 cannabinoid receptor. The CB1 receptor has been shown to couple to the stress-activated protein kinase, c-Jun N-terminal kinase (JNK). However, the involvement of specific JNK isoforms in the neurotoxic properties of THC remains to be established. The present study involved treatment of rat cultured cortical neurons with THC (0.005-50 microM), and combinations of THC with the CB1 receptor antagonist, AM 251 (10 microM) and pertussis toxin (PTX; 200 ng ml-1). Antisense oligonucleotides (AS) were used to deplete neurons of JNK1 and JNK2 in order to elucidate their respective roles in THC signalling. Here we report that THC induces the activation of JNK via the CB1 receptor and its associated G-protein, Gi/o. Treatment of cultured cortical neurons with THC resulted in a differential timeframe of activation of the JNK1 and JNK2 isoforms. Use of specific JNK1 and JNK2 AS identified activation of caspase-3 and DNA fragmentation as downstream consequences of JNK1 and JNK2 activation. The results from this study demonstrate that activation of the CB1 receptor induces JNK and caspase-3 activation, an increase in Bax expression and DNA fragmentation. The data demonstrate that the activation of both JNK1 and JNK2 isoforms is central to the THC-induced activation of the apoptotic pathway in cortical neurons.

Entities:  

Mesh:

Substances:

Year:  2003        PMID: 14522843      PMCID: PMC1574055          DOI: 10.1038/sj.bjp.0705464

Source DB:  PubMed          Journal:  Br J Pharmacol        ISSN: 0007-1188            Impact factor:   8.739


  60 in total

Review 1.  Reverse pharmacology applied to the cannabinoid receptor.

Authors:  A C Howlett
Journal:  Trends Pharmacol Sci       Date:  1990-10       Impact factor: 14.819

Review 2.  Pharmacology of cannabinoid receptors.

Authors:  A C Howlett
Journal:  Annu Rev Pharmacol Toxicol       Date:  1995       Impact factor: 13.820

3.  Signal transduction pathways regulated by mitogen-activated/extracellular response kinase kinase kinase induce cell death.

Authors:  N L Johnson; A M Gardner; K M Diener; C A Lange-Carter; J Gleavy; M B Jarpe; A Minden; M Karin; L I Zon; G L Johnson
Journal:  J Biol Chem       Date:  1996-02-09       Impact factor: 5.157

4.  Signaling from G protein-coupled receptors to c-Jun kinase involves beta gamma subunits of heterotrimeric G proteins acting on a Ras and Rac1-dependent pathway.

Authors:  O A Coso; H Teramoto; W F Simonds; J S Gutkind
Journal:  J Biol Chem       Date:  1996-02-23       Impact factor: 5.157

5.  Activation of mitogen-activated protein kinases by stimulation of the central cannabinoid receptor CB1.

Authors:  M Bouaboula; C Poinot-Chazel; B Bourrié; X Canat; B Calandra; M Rinaldi-Carmona; G Le Fur; P Casellas
Journal:  Biochem J       Date:  1995-12-01       Impact factor: 3.857

6.  Cannabinoids activate an inwardly rectifying potassium conductance and inhibit Q-type calcium currents in AtT20 cells transfected with rat brain cannabinoid receptor.

Authors:  K Mackie; Y Lai; R Westenbroek; R Mitchell
Journal:  J Neurosci       Date:  1995-10       Impact factor: 6.167

7.  Anadamide, an endogenous cannabinoid receptor agonist inhibits lymphocyte proliferation and induces apoptosis.

Authors:  H Schwarz; F J Blanco; M Lotz
Journal:  J Neuroimmunol       Date:  1994-11       Impact factor: 3.478

8.  Signaling pathway associated with stimulation of CB2 peripheral cannabinoid receptor. Involvement of both mitogen-activated protein kinase and induction of Krox-24 expression.

Authors:  M Bouaboula; C Poinot-Chazel; J Marchand; X Canat; B Bourrié; M Rinaldi-Carmona; B Calandra; G Le Fur; P Casellas
Journal:  Eur J Biochem       Date:  1996-05-01

9.  The Ottawa Prenatal Prospective Study (OPPS): methodological issues and findings--it's easy to throw the baby out with the bath water.

Authors:  P A Fried
Journal:  Life Sci       Date:  1995       Impact factor: 5.037

10.  Opposing effects of ERK and JNK-p38 MAP kinases on apoptosis.

Authors:  Z Xia; M Dickens; J Raingeaud; R J Davis; M E Greenberg
Journal:  Science       Date:  1995-11-24       Impact factor: 47.728

View more
  16 in total

Review 1.  Neurons on cannabinoids: dead or alive?

Authors:  Manuel Guzman
Journal:  Br J Pharmacol       Date:  2003-10       Impact factor: 8.739

Review 2.  The complications of promiscuity: endocannabinoid action and metabolism.

Authors:  S P H Alexander; D A Kendall
Journal:  Br J Pharmacol       Date:  2007-09-17       Impact factor: 8.739

3.  Inhibition by anandamide of 6-hydroxydopamine-induced cell death in PC12 cells.

Authors:  Katarzyna Mnich; David P Finn; Eilis Dowd; Adrienne M Gorman
Journal:  Int J Cell Biol       Date:  2010-02-16

4.  Regulation of Fas receptor/Fas-associated protein with death domain apoptotic complex and associated signalling systems by cannabinoid receptors in the mouse brain.

Authors:  M Alvaro-Bartolomé; S Esteban; M S García-Gutiérrez; J Manzanares; O Valverde; J A García-Sevilla
Journal:  Br J Pharmacol       Date:  2010-06       Impact factor: 8.739

Review 5.  The endocannabinoid system in the physiology and pathophysiology of the gastrointestinal tract.

Authors:  Federico Massa; Martin Storr; Beat Lutz
Journal:  J Mol Med (Berl)       Date:  2005-08-26       Impact factor: 4.599

6.  2-Arachidonoylglycerol stimulates activator protein-1-dependent transcriptional activity and enhances epidermal growth factor-induced cell transformation in JB6 P+ cells.

Authors:  Qing Zhao; Zhiwei He; Nanyue Chen; Yong-Yeon Cho; Feng Zhu; Chengrong Lu; Wei-Ya Ma; Ann M Bode; Zigang Dong
Journal:  J Biol Chem       Date:  2005-05-10       Impact factor: 5.157

Review 7.  Cannabis and alcohol use, and the developing brain.

Authors:  A D Meruelo; N Castro; C I Cota; S F Tapert
Journal:  Behav Brain Res       Date:  2017-02-20       Impact factor: 3.332

Review 8.  The dual neuroprotective-neurotoxic profile of cannabinoid drugs.

Authors:  Yosef Sarne; Fadi Asaf; Miriam Fishbein; Mikhal Gafni; Ora Keren
Journal:  Br J Pharmacol       Date:  2011-08       Impact factor: 8.739

Review 9.  Endocannabinoids and reactive nitrogen and oxygen species in neuropathologies.

Authors:  Allyn C Howlett; Somnath Mukhopadhyay; Derek C Norford
Journal:  J Neuroimmune Pharmacol       Date:  2006-06-24       Impact factor: 4.147

10.  c-Jun N terminal kinase signaling pathways mediate cannabinoid tolerance in an agonist-specific manner.

Authors:  Angela N Henderson-Redmond; Caitlin M Nealon; Brian J Davis; Matthew B Yuill; Diana E Sepulveda; Henry L Blanton; Mary K Piscura; Michael L Zee; Chris P Haskins; David J Marcus; Ken Mackie; Josée Guindon; Daniel J Morgan
Journal:  Neuropharmacology       Date:  2019-11-20       Impact factor: 5.250

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.